GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anthem Biosciences ANTHEM.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

958.15

+4.65%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹21.24bn

FY2022FY2026

Net income

₹5.92bn

FY2022FY2026

Free cash flow

₹7.06bn

FY2022FY2026

Shareholders' equity

₹30.43bn

FY2022FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Revenue₹21.24bn₹18.45bn₹14.19bn₹10.57bn₹12.31bn
Research and development₹181.5m₹195.2m₹231.6m₹258.6m₹247.9m
Operating income₹7.07bn₹5.92bn₹4.25bn₹3.72bn₹5.49bn
Net income₹5.92bn₹4.51bn₹3.67bn₹3.85bn₹4.06bn
Diluted earnings per share10.417.976.546.787.13

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Total assets₹34.29bn₹28.08bn₹23.98bn₹20.14bn₹16.19bn
Cash and short-term investments₹9.40bn₹7.32bn———
Total liabilities₹3.87bn₹3.98bn₹4.73bn₹2.74bn₹2.64bn
Debt₹539.2m₹1.13bn₹1.12bn₹961.9m₹45.9m
Shareholders' equity₹30.43bn₹24.10bn₹19.25bn₹17.41bn₹13.55bn
Shares outstanding568m566m562m568m568m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Cash from operations₹9.17bn₹4.18bn₹1.40bn₹3.06bn₹3.33bn
Capital spending−₹2.11bn−₹3.15bn−₹2.97bn−₹1.95bn−₹1.61bn
Free cash flow₹7.06bn₹1.04bn−₹1.57bn₹1.11bn₹1.72bn
Dividends paid————−₹10,000

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹4.17bn₹6.09bn₹4.23bn₹5.47bn₹5.39bn₹4.83bn₹4.95bn₹5.21bn
Operating income₹1.21bn₹2.28bn₹1.23bn₹1.84bn₹1.65bn₹1.75bn₹1.39bn₹1.75bn
Net income₹1.20bn₹1.90bn₹928.2m₹1.73bn₹1.36bn₹826.2m₹1.24bn₹1.62bn
Diluted earnings per share2.113.341.643.062.401.462.212.88
Cash from operations———₹4.03bn—₹2.31bn——
Capital spending———−₹1.28bn—−₹1.97bn——
Free cash flow———₹2.75bn—₹338.0m——
Total assets—₹34.29bn—₹32.84bn—₹28.08bn—₹26.93bn
Cash and short-term investments—₹9.40bn—₹11.00bn—₹7.32bn—₹6.75bn
Debt—₹530.4m—₹1.08bn—₹1.10bn—₹1.32bn
Shareholders' equity—₹30.43bn—₹27.53bn—₹24.10bn—₹22.04bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue24.8%——
Operating income23.9%——
Net income15.4%——

Valuation history

At each fiscal year end

FY2026FY2025
Price to earnings87.581.7
Price to sales25.420.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.